[Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR(+)CD25⁻ cell subset in patients with systemic lupus erythematosus].

OBJECTIVES Regulatory T cells (T(REG)) represent a T cell subset able to modulate immune response by suppressing autoreactive T-lymphocytes. The evidence of a reduced number and an impaired function of this cell population in autoimmune/inflammatory chronic diseases led to the hypothesis of its involvement in the pathogenesis of these disorders. Glucocorticoid-induced TNFR-related protein (GITR) is a well known marker of murine T(REG) cells, but little is known in humans. The aim of this study was to investigate the characteristics of T(REG) cells in systemic lupus erythematosus (SLE) and the potential role of GITR as marker of human T(REG). METHODS Nineteen SLE patients and 15 sex- and age-matched normal controls (NC) were enrolled. CD4(+) T cells were magnetic sorted from peripheral blood by negative selection. Cell phenotype was analyzed through flow-cytometry using primary and secondary antibodies and real time polymerase-chain reaction (PCR) using TaqMan probes. RESULTS The CD25(high)GITR(high) subset was significantly decreased in SLE patients with respect to NC (0.37±0.21% vs 0.72±0.19%; p<0.05). On the opposite, the CD25⁻GITR(high) cell population was expanded in the peripheral blood of SLE patients (3.5±2.25 vs 0.70±0.32%, p<0.01). Interestingly, FoxP3 at mRNA level was expressed in both CD25⁻GITR(high) and CD25(high)GITR(high) cells, suggesting that both cell subsets have regulatory activity. CONCLUSIONS CD4(+)CD25⁻GITR(high) cells are increased in SLE as compared to NC. The expression of high level of GITR, but not CD25, on FoxP3+ cells appears to point to a regulatory phenotype of this peculiar T cell subset.

[1]  C. Riccardi,et al.  Role of regulatory T cells in rheumatoid arthritis: facts and hypothesis , 2010, Autoimmunity Highlights.

[2]  P. Krammer,et al.  CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood. , 2010, The Journal of investigative dermatology.

[3]  J. Smolen,et al.  Treg and lupus , 2009, Annals of the rheumatic diseases.

[4]  Jonathan H. Esensten,et al.  Regulatory T cells as therapeutic targets in rheumatoid arthritis , 2009, Nature Reviews Rheumatology.

[5]  C. Benoist,et al.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes , 2009, Nature Immunology.

[6]  P. Lipsky,et al.  Clinical significance of increased CD4+CD25−Foxp3+ T cells in patients with new-onset systemic lupus erythematosus , 2008, Annals of the rheumatic diseases.

[7]  C. Kuo,et al.  The quantitative analysis of peripheral blood FOXP3‐expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients , 2007, European journal of clinical investigation.

[8]  S. Sipka,et al.  Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus , 2007, Lupus.

[9]  S. Cuzzocrea,et al.  GITR/GITRL: More than an effector T cell co‐stimulatory system , 2007, European journal of immunology.

[10]  J. Verbsky.  Therapeutic use of T regulatory cells , 2007, Current opinion in rheumatology.

[11]  J. Pfeilschifter,et al.  Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[12]  J. Bijlsma,et al.  Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[13]  P. Lipsky,et al.  Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus1 , 2007, The Journal of Immunology.

[14]  J. Woo,et al.  Increase in circulating Foxp3+CD4+CD25high regulatory T cells in nasopharyngeal carcinoma patients , 2007, British Journal of Cancer.

[15]  Y. Wang,et al.  Accumulation of FoxP3‐expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis , 2007, Scandinavian journal of rheumatology.

[16]  P. Emery,et al.  Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. , 2006, Rheumatology.

[17]  J. Andreu,et al.  Decrease of regulatory T cells in patients with systemic lupus erythematosus , 2006, Annals of the rheumatic diseases.

[18]  P. Debré,et al.  Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus1 , 2005, The Journal of Immunology.

[19]  L-L Fung,et al.  The Presence of Cytokine‐Suppressive CD4+CD25+ T Cells in the Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis , 2005, Scandinavian journal of immunology.

[20]  E. Mazzon,et al.  Role of glucocorticoid‐induced TNF receptor family gene (GITR) in collagen‐induced arthritis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  R. Toes,et al.  Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. , 2005, Arthritis and rheumatism.

[22]  P. Isomäki,et al.  CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis , 2005, Clinical and experimental immunology.

[23]  A. Billiau,et al.  Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-γ , 2005, Arthritis research & therapy.

[24]  J. Bijlsma,et al.  CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. , 2004, Arthritis and rheumatism.

[25]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[26]  J. Alcocer-Varela,et al.  Quantification of regulatory T cells in patients with systemic lupus erythematosus. , 2003, Journal of autoimmunity.

[27]  H. Ochs,et al.  Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis , 2003, Current opinion in rheumatology.

[28]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[29]  C. Baecher-Allan,et al.  Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis , 2003, European journal of immunology.

[30]  G. Schuler,et al.  Human CD4+CD25+ Regulatory, Contact-dependent T Cells Induce Interleukin 10–producing, Contact-independent Type 1-like Regulatory T Cells , 2002, The Journal of experimental medicine.

[31]  G. Schuler,et al.  Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood , 2001, The Journal of experimental medicine.

[32]  A. Bowcock,et al.  JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. , 2000, The Journal of clinical investigation.

[33]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[34]  C. Riccardi,et al.  A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[36]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[37]  D. Lawrence,et al.  CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. , 2008, Cellular immunology.